Rebleeding risk rises with transfusions for patients with NVUGIB

01/31/2013 | Healio

A study published in Alimentary Pharmacology & Therapeutics linked red blood cell transfusions with increased rebleeding risk in patients with nonvariceal upper gastrointestinal bleeding. Transfusions also were associated with greater all-cause mortality. The study of 1,677 patients was limited, according to researchers, but the findings "support the need for a prospective randomized trial."

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY